• BX Home
  • Pharmaceutical Industry: [Page 46]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL INDUSTRY

The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.

Pharmaceutical Industry is part of Business Exchange, suggested by Ken Rhines. This topic contains 2,085 news and 770 blog items. Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancermore

Elotuzumab: Anti-CS1 Antibody for Multiple Myelomamore

Healthcare processing JVs aheadmore

We last called David Ernst of joint venture consultancy Water Street Partners in February to discuss why so many JVs...

Drug Industry Seeks to Influence Health Care Debatemore

Major drug makers want their voices heard as U.S. Democrats, traditionally critics of the industry, start crafting...

Sanofi Settles Suits With Rivals On U.S. Sales of Generic Allegramore

Sanofi-Aventis SA said it settled litigation with two drug makers over U.S. sales of generic copies of its allergy...

Inovio developing a swine flu vaccinemore

FDA Approves Multaq (dronedarone) to Treat Heart Rhythm Disordermore

Does Lantus (insulin glargine) increase the risk of breast cancer?more

FDA: Boxed warning for Chantix and Zybanmore

U.S. advisers call for ban of some pain drugs more

Advisors to the FDA recommended banning Vicodin and Percocet.

If you don’t think there is a trust issue in pharma, then you haven’t ...more

Particle Sciences and Microfluidics to Share Formulation and Nanotechn...more

Microfluidics, a wholly owned subsidiary of and Particle Sciences Inc have formed a strategic alliance to help...

Glaxo CEO discusses R&D overhaul more

GlaxoSmithKline's chief executive acknowledged on Friday that overhauling its research operation was traumatic.

Teva Is Ready for Major Acquisition, Chief Says more

Teva Pharmaceutical Industries Ltd., which bought Barr Laboratories Inc. for $7.4 billion last year, is ready for...

Sanofi Chief Executive Says U.S. Acquisition Isn’t a Certaintymore

Sanofi-Aventis SA Chief Executive Officer Chris Viehbacher says a U.S. takeover isn’t necessarily in the cards for...

Big Pharma gets green kudos for carbon-trackingmore

Posted on Carbon Offsets Daily, Climate Counts recently released a scorecard for pharma.

Frost & Sullivan predicts shift of big pharma towards biologicsmore

The recent surge in M&A activities, with four in the first half of 2009 alone, cannot solely be attributed to the...

Generic Biotech Drugs: Cure or Quagmire?more

When President Barack Obama spoke to the American Medical Assn. on June 15, he couldn't quite quantify the potential...

FDA Panel Recommends Psych Drugs for Kidsmore

An advisory panel of the Food and Drug Administration said two leading antipsychotic medications should be approved for...

Vaccines Studies open to developing countriesmore

According to an article at Fierce Vaccines, the University of Sienna and Novartis Vaccines and Diagnostics will be...

FTC: 12-14 yrs too long to protect biotech drugsmore

Generic versions of expensive biotechnology drugs would reduce the amount of money spent on health care in the United...

Nissen Argues Blockbusters are Deadmore

The Cleveland Clinic doc is urging the federal government to back the creation of novel treatments.

Merck's Heart Failure Failuremore

The failure of a Merck drug to treat acute heart failure in a large clinical trial raises new questions about the...

Slump Pushing Cost of Drugs Out of Reachmore

Even with the Medicare drug benefit, even with the prevalence of low-cost generics, even with loss-leader discounting...

Sanofi-Aventis Settles Medicaid Price Disputemore

Sanofi-Aventis SA will pay $95.5 million to settle allegations that it overcharged state Medicaid programs for...

Topic Feed: Most active content in Pharmaceutical Industry

Top Sources: Pharmaceutical Industry

  • BusinessWeek
  • bloomberg.com
  • pharmachemicalscoatings.blogspot.com
  • Reuters
  • srcomblog.wordpress.com
  • New York Times
  • Industry Week
  • pharmatching.com
  • myharvardnews.com
  • online.wsj.com

Most Active Users in this Topic

see all contributors in Pharmaceutical Industry

Featured White Papers

Tweets on this Topic

Post a Job

Jobs in this Topic

Pharmaceutical Sales Representative Caswood Group | Los Angeles, CA
Posted: May 25
Advisory Health Industries R&D Director PwC | Jersey City, NJ
Posted: May 27
Health Industries IT Pharma Managed Markets Manager PwC | Philadelphia, PA
Posted: Mar 9
Senior Manager, Managed Markets (Pharmaceutical) Novo Nordisk | Princeton, NJ
Posted: May 28
Editor - Online B2B Pharmaceutical Publications Online B2B Pharmaceutical Publications | New York, NY
Posted: May 7

Report comment contains invalid characters. ()
cancel
Search Cancel